Genetics & Stem Cells News

Medindia's Press Release’ section provides the latest press release on Genetics & Stem Cells from across the world for the global audience. This page links to 1947 Genetics & Stem Cells press releases.

Aurora Pharmaceutical Delivers on FDA-Approved Generic for Equine Pain Relief

PR Newswire NORTHFIELD, Minn., Feb. 13, 2025 NORTHFIELD, Minn., Feb. 13, 2025 /PRNewswire/ -- Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a ...

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

PR Newswire TOKYO, Feb. 13, 2025 TOKYO, Feb. 13, 2025 /PRNewswire/ -- Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II ...

Hematopoietic Stem Cell Transplant Patients Rarely Tested for Penicillin Allergy

PR Newswire MILWAUKEE, Feb. 12, 2025 Inaccurate penicillin allergy labels limit access to preferred antibiotics MILWAUKEE, Feb. 12, 2025 /PRNewswire-PRWeb/ -- Immunocompromised patients undergoing hematopoietic stem cell transplants ...

CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B

PR Newswire KING OF PRUSSIA, Pa., Feb. 7, 2025 KING OF PRUSSIA, Pa., Feb. 7, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the four-year results from the pivotal HOPE-B study confirming the ...

Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion

PR Newswire ZWINGENBERG, Germany, Feb. 4, 2025 ZWINGENBERG, Germany, Feb. 4, 2025 /PRNewswire/ -- Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell ...

Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients

PR Newswire SAN MATEO, Calif., Feb. 3, 2025 SAN MATEO, Calif., Feb. 3, 2025 /PRNewswire/ -- Helix, a leader in precision health, is unveiling a new comprehensive clinico-genomic dataset of over 15,000 patients treated with ...

Avirmax Biopharma Announces Completion of the First Cohort of Patient Enrollment in Clinical Trial of ABI-110, a Gene Therapy for Wet AMD Including PCV

PR Newswire HAYWARD, Calif., Feb. 3, 2025 HAYWARD, Calif., Feb. 3, 2025 /PRNewswire/ -- Avirmax Biopharma, Inc., a leader in the development of the next generation of AAV gene therapies, today announced completion of the first cohort of the ...

jscreen Announces the Sixth Annual Jewish Genetic Screening Awareness Week (JGSAW) February 2nd - 8th

PR Newswire ATLANTA, Jan. 31, 2025 Empowering Jewish Families Through Knowledge and Genetic Testing ATLANTA, Jan. 31, 2025 /PRNewswire/ -- jscreen, a national non-profit public health initiative dedicated to preventing genetic diseases, ...

FAST-AFFILIATED RESEARCH PROGRAM AT UCLA IS AWARDED $5.8M TO ADVANCE GENE THERAPY FOR ANGELMAN SYNDROME

PR Newswire AUSTIN, Texas, Jan. 30, 2025 AUSTIN, Texas, Jan. 30, 2025 /PRNewswire/ -- Dr. Roger Hollis from the University of California, Los Angeles, project scientist from the laboratory of Dr. Donald Kohn, a world leader in developing ...

Building a Playbook for Cell and Gene Therapies for Autoimmune Disease: Navigating a Rapidly Evolving Environment, Upcoming Webinar Hosted by Xtalks

PR Newswire TORONTO, Jan. 30, 2025 In this free webinar, learn about the impact of cell and gene therapies on the current standard of care for patients with autoimmune disease. Attendees will delve into the rapid advancements in clinical ...

First Prev
1
2
3
4
5
6
7
8
9
10
Next
Last